Literature DB >> 7784245

Unusual combination of congenital heart defects in an infant with Noonan syndrome.

L R Feit1, K Hansen, C E Oyer, J C Werner.   

Abstract

Congenital heart disease occurs in 35-50% of patients diagnosed with Noonan syndrome. We present an infant with an unusual combination of congenital heart defects not previously reported, including partial atrioventricular septal defect, polyvalvular dysplasia, and progressive hypertrophic cardiomyopathy. We discuss the possible interaction between these lesions that may have led to the patient's rapid demise.

Entities:  

Mesh：

Year:  1995        PMID： 7784245     DOI： 10.1007/BF00796828

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  12 in total

Review 1.  Association of congenital heart disease with syndromes or other defects.

Authors:  J A Noonan
Journal:  Pediatr Clin North Am       Date:  1978-11       Impact factor: 3.278

2.  Echocardiographic measurements in normal preterm and term neonates.

Authors:  F J Walther; B Siassi; J King; P Y Wu
Journal:  Acta Paediatr Scand       Date:  1986-07

3.  Congenital heart disease in male and female subjects with somatic features of Turner's syndrome and normal sex chromosomes (Ullrich's and related syndromes).

Authors:  D C Siggers; P E Polani
Journal:  Br Heart J       Date:  1972-01

4.  The Ullrich-Noonan syndrome (Turner phenotype).

Authors:  J J Nora; A H Nora; A K Sinha; R D Spangler; H A Lubs
Journal:  Am J Dis Child       Date:  1974-01

5.  Eccentric ventricular hypertrophy in familial and sporadic instances of 46 XX, XY Turner phenotype.

Authors:  K H Ehlers; M A Engle; A R Levin; W J Deely
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

6.  Dimensions of normal human hearts after standard fixation by controlled pressure coronary perfusion.

Authors:  F A Eckner; B W Brown; D L Davidson; S Glagov
Journal:  Arch Pathol       Date:  1969-11

7.  Echocardiographic studies of left ventricular disease in Ullrich-Noonan syndrome.

Authors:  J J Nora; R H Lortscher; R D Spangler
Journal:  Am J Dis Child       Date:  1975-12

8.  Rapidly progressive obstructive cardiomyopathy in infants with Noonan's syndrome. Report of two cases.

Authors:  H D Hirsch; H Gelband; O Garcia; S Gottlieb; D M Tamer
Journal:  Circulation       Date:  1975-12       Impact factor: 29.690

9.  Cardiovascular malformations in Turner's and Noonan's syndrome.

Authors:  L G Van der Hauwaert; J P Fryns; M Dumoulin; N Logghe
Journal:  Br Heart J       Date:  1978-05

10.  Myocardial disarray in Noonan syndrome.

Authors:  M Burch; J M Mann; M Sharland; E A Shinebourne; M A Patton; W J McKenna
Journal:  Br Heart J       Date:  1992-12
View more
  5 in total

1.  Partial atrioventricular canal with left-sided obstruction in patients with Noonan syndrome.

Authors:  B Marino; M C Digilio; M G Gagliardi; A Giannotti; B Dallapiccola
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

2.  Atrioventricular canal defect in patients with RASopathies.

Authors:  Maria Cristina Digilio; Francesca Romana Lepri; Maria Lisa Dentici; Alex Henderson; Anwar Baban; Maria Cristina Roberti; Rossella Capolino; Paolo Versacci; Cecilia Surace; Adriano Angioni; Marco Tartaglia; Bruno Marino; Bruno Dallapiccola
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

3.  Prolapse of all cardiac valves in Noonan syndrome.

Authors:  Adikesava Naidu Otikunta; Y V Subbareddy; Praneeth Polamuri; Ashok Thakkar
Journal:  BMJ Case Rep       Date:  2015-02-25

4.  Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy.

Authors:  William Gibson; Cynthia Trevenen; Michael Giuffre; Alexander K C Leung
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

5.  Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies.

Authors:  Dena R Matalon; David A Stevenson; Elizabeth J Bhoj; Avni B Santani; Beth Keena; Meryl S Cohen; Angela E Lin; Sarah E Sheppard; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2021-03-08       Impact factor: 2.802
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.